Galapagos NV
GLPG
#4956
Rank
ยฃ1.38 B
Marketcap
ยฃ20.64
Share price
0.00%
Change (1 day)
-2.91%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): ยฃ0.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ1.22 Billion. In 2025 the company made an earning of ยฃ0.27 Billion, an increase over its 2024 earnings that were of -ยฃ4.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ0.41 B50.59%
2025 ยฃ0.27 B-6464.81%
2024 -ยฃ4.31 Million-82.77%
2023 -ยฃ24.97 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.28 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.55 Million-72.34%
2017 -ยฃ99.6 Million-329.59%
2016 ยฃ43.38 M-144.3%
2015 -ยฃ97.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.33 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.05 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.91 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.70 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ9.79 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.91 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ7.45 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ39.81 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.69 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel